The firm is selling its Zinnat operation to Swiss-owned Sandoz, which will transfer manufacturing to its own plants in Austria. GSK's site in Ulverston, Cumbria, and its Zinnat buildings in ...

Austria and Switzerland. GSK will make an upfront payment of €75m and a further payment of €75m, conditional on the achievement of certain goals. At the Veeva Commercial Summit in Madrid at ...